Literature DB >> 8967744

Superoxide dismutase and familial amyotrophic lateral sclerosis: new insights into mechanisms and treatments.

R H Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8967744     DOI： 10.1002/ana.410390202

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  4 in total

Review 1.  Progress in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  C E Shaw; A al-Chalabi; N Leigh
Journal:  Curr Neurol Neurosci Rep       Date:  2001-01       Impact factor: 5.081

Review 2.  Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis.

Authors:  G C Román
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

Review 3.  Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis.

Authors:  H M Bryson; B Fulton; P Benfield
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 4.  The role of creatine in the management of amyotrophic lateral sclerosis and other neurodegenerative disorders.

Authors:  Amy Cameron Ellis; Jeffrey Rosenfeld
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.